Abcam PLC (ABCM)       14.46  +0.09 (+0.63%)

Company Profile

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.

Company Info

Abcam PLC

Discovery Drive, Cambridge Biomedical Campus, Hills Road

Cambridge CAMBRIDGESHIRE CB2 0AX

P: 441223696000.0

CEO: Alan Hirzel

Employees: 1750

Website: http://www.abcam.com/